These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Gold therapy in bronchial asthma with special emphasis upon blood level of gold and its teratogenicity (author's transl)]. Miyamoto T; Miyaji S; Horiuchi Y; Hara M; Ishihara K Nihon Naika Gakkai Zasshi; 1974 Oct; 63(10):1190-7. PubMed ID: 4215854 [No Abstract] [Full Text] [Related]
6. [Pneumonitis as a consequence of gold therapy]. Skralovnik-Stern A; Glücks A; Stern A; Remskar J; Simcić A Plucne Bolesti; 1986; 38(3-4):248-52. PubMed ID: 3108913 [No Abstract] [Full Text] [Related]
7. [One case of pulmonary fibrosis occurring during gold therapy and review of chest X-rays of asthmatic patients receiving gold therapy (author's transl)]. Kudo K; Miyamoto T; Horiuchi Y Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Sep; 15(9):646-52. PubMed ID: 338952 [No Abstract] [Full Text] [Related]
8. Pulmonary injury induced by gold salts treatment. Schapira D; Nahir M; Scharf Y Med Interne; 1985; 23(4):259-63. PubMed ID: 2935924 [TBL] [Abstract][Full Text] [Related]
9. [T-lymphocytosis and lymphokines in bronchoalveolar lavage fluid of a gold salt-induced pneumonitis]. Ikeda S; Chikazawa C; Naoe H; Manba K; Yasuda K; Yastake T; Honda M Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Nov; 24(11):1258-65. PubMed ID: 3104641 [No Abstract] [Full Text] [Related]
10. [A case of cryptogenic fibrosing pneumonitis, successfully treated with large doses of steroids, and maintained without recurrence for five years (author's transl)]. Ozawa K; Kawaguchi T; Kobayashi T; Mochizuki I; Kusama S; Kamiyama K; Shirosaki T Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Apr; 18(4):260-6. PubMed ID: 7392329 [No Abstract] [Full Text] [Related]
11. [A case of gold-induced pneumonitis showing a positive reaction in the drug lymphocyte stimulation test (DLST) for gold]. Bando M; Takishita Y; Bando H; Hashimoto Y; Sano T Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):128-32. PubMed ID: 1625388 [TBL] [Abstract][Full Text] [Related]
12. [Gold therapy in chronic polyarthritis. Differentiation of allergic and toxic side effects]. Bene E; Megyeri A; Györi J Z Rheumatol; 1980; 39(3-4):109-16. PubMed ID: 6448525 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485 [TBL] [Abstract][Full Text] [Related]
17. [Fatal pulmonary fibrosis caused by gold therapy?]. Chatzigiannis I; Schmidt KL; Stambolis C Z Rheumatol; 1984; 43(2):49-58. PubMed ID: 6428074 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis. Edelman J; Davis P; Owen ET J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032 [TBL] [Abstract][Full Text] [Related]
19. IV N-acetylcysteine treatment of hematologic reactions to chrysotherapy. Godfrey NF; Peter A; Simon TM; Lorber A J Rheumatol; 1982; 9(4):519-26. PubMed ID: 6813467 [TBL] [Abstract][Full Text] [Related]
20. [Personal experience of treatment of interstitial pulmonary fibrosis with corticosteroids (author's transl)]. Vereerstraeten J; Tombroff M; Koster JP Acta Tuberc Pneumol Belg; 1974; 65(6):584-93. PubMed ID: 4466347 [No Abstract] [Full Text] [Related] [Next] [New Search]